Biolinx Global

Biolinx Global is a biotech venture studio and innovation catalyst that operates to transform health security in Africa by building competitive biotech and medtech startups. Born from Villgro Africa and led by Dr. Robert Muhia Karanja, the organization functions through its Bioxcelerator Venture Studio model, which scouts health talent and ideas to co-create solutions across a development pipeline from ideation to investment-ready status. The entity is also established in the United Kingdom as a private limited company focused on activities related to venture and development capital, research and experimental development on biotechnology, and business support services.

By bridging local scientific ingenuity with global resources, the company facilitates advancements in genomics, proteomics, diagnostics, precision medicine, and medtech tailored for African populations. It serves as a vital market-entry partner for global developers by offering assistance with business-model validation, regulatory navigation, and the coordination of local manufacturing or distribution partnerships. Through these efforts, the organization seeks to strengthen the healthcare innovation ecosystem in Africa, supported by regional partnerships in genomics and health infrastructure.